T1	Microorganism 9 35	Anaerobutyricum soehngenii
T2	INCREASES 2042 2052	stimulates
T3	Chemical 56 61	GLP-1
T4	IMPROVES 74 85	ameliorates
T5	Physiology 86 103	glycaemic control
T6	Physiology 132 154	duodenal transcriptome
T7	Population 158 185	metabolic syndrome subjects
T8	Methodology 189 248	randomised double-blind placebo-controlled cross-over study
T9	Disease 269 282	gut dysbiosis
T10	Disease 347 365	metabolic syndrome
T11	Disease 367 371	MetS
T12	PREDISPOSES 315 343	pathophysiological component
T13	Microorganism 515 541	Anaerobutyricum soehngenii
T14	IMPROVES 548 572	associated with improved
T15	Physiology 573 592	insulin sensitivity
T16	Population 596 614	subjects with MetS
T17	Disease 610 614	MetS
T18	Microorganism 701 719	A. soehngenii L2-7
T19	INCREASES 45 55	stimulates
T20	Physiology 723 751	systemic metabolic responses
T21	Measurement 756 787	duodenal transcriptome profiles
T22	Population 791 812	individuals with MetS
T23	Disease 808 812	MetS
T24	Methodology 829 888	randomised double-blind placebo-controlled cross-over study
T25	Population 893 906	male subjects
T26	Disease 912 916	MetS
T27	Microorganism 948 961	A. soehngenii
T28	Methodology 985 1002	duodenal biopsies
T29	Methodology 1004 1020	mixed meal tests
T30	Methodology 1048 1085	24-hour continuous glucose monitoring
T31	Microorganism 1096 1109	A. soehngenii
T32	INCREASES 1140 1149	increased
T33	Chemical 1203 1226	glucagon-like peptide 1
T34	Chemical 1228 1233	GLP-1
T35	INCREASES 1242 1251	elevation
T36	Metabolite 1262 1282	secondary bile acids
T37	POS_ASSOCIATED_WITH 1295 1316	positively associated
T38	Chemical 1322 1327	GLP-1
T39	Microorganism 1346 1359	A. soehngenii
T40	AFFECTS 1379 1385	shaped
T41	Gene 1476 1527	regenerating islet-protein 1B (REG1B)-encoding gene
T43	Gene 1550 1555	REG1B
T44	POS_ASSOCIATED_WITH 1567 1588	positively correlated
T45	Chemical 1594 1599	GLP-1
T46	NEG_ASSOCIATED_WITH 1611 1632	negatively correlated
T47	Physiology 1638 1668	peripheral glucose variability
T48	DECREASES 1694 1704	diminished
T49	Microorganism 1731 1744	A. soehngenii
T50	Gene 1770 1775	Reg1B
T51	INCREASES 1790 1797	induced
T52	Metabolite 1811 1819	butyrate
T53	Metabolite 1823 1846	bacterial peptidoglycan
T54	Microorganism 1861 1874	A. soehngenii
T55	Microorganism 1957 1970	A. soehngenii
T56	IMPROVES 1971 1979	improves
T57	Physiology 1980 2008	peripheral glycaemic control
T59	Chemical 2064 2069	GLP-1
T60	Gene 2085 2090	REG1B
T61	Gene 2177 2182	REG1B
T62	Physiology 2209 2228	insulin sensitivity
T63	IMPROVES 108 127	beneficially shapes
T64	Disease 158 176	metabolic syndrome
T65	Physiology 430 446	metabolic health
T66	IMPROVES 678 697	therapeutic effects
E1	INCREASES:T19 Agent:T1 Theme:T3
E2	IMPROVES:T4 Agent:T1 Theme:T5
E4	PREDISPOSES:T12 Agent:T9 Theme:T10
E5	IMPROVES:T14 Agent:T13 Theme:T15
E6	IMPROVES:T66 Agent:T18 Theme:T21
E7	IMPROVES:T66 Agent:T18 Theme:T20
E8	INCREASES:T32 Agent:T31 Theme:T33
E9	INCREASES:T35 Agent:T31 Theme:T36
E10	POS_ASSOCIATED_WITH:T37 Agent:T36 Theme:T38
E11	AFFECTS:T40 Agent:T39 Theme:T41
E12	POS_ASSOCIATED_WITH:T44 Agent:T43 Theme:T45
E13	NEG_ASSOCIATED_WITH:T46 Agent:T43 Theme:T47
E14	DECREASES:T48 Agent:T49 Theme:T47
E15	INCREASES:T51 Theme:T50 Agent:T52
E16	INCREASES:T51 Theme:T50 Agent:T53
E17	IMPROVES:T56 Agent:T55 Theme:T57
E18	INCREASES:T2 Agent:T55 Theme:T59
E19	INCREASES:T2 Agent:T55 Theme:T60
E20	IMPROVES:T63 Theme:T6 Agent:T1
A1	Factuality E6 Unknown
A2	Factuality E7 Unknown
N1	Reference T1 NCBITAXON:105843	Anaerobutyricum soehngenii
N2	Reference T3 CHEBI:80270	Glucagon-like peptide 1
N3	Reference T5 MESH:D000085002	Glycemic Control
N4	Reference T9 MESH:D064806	Dysbiosis
N5	Reference T10 NCIT:C84442	Metabolic Syndrome
N6	Reference T11 NCIT:C84442	Metabolic Syndrome
N7	Reference T13 NCBITAXON:105843	Anaerobutyricum soehngenii
N8	Reference T15 OCHV:C0920563	insulin sensitivity
N9	Reference T17 NCIT:C84442	Metabolic Syndrome
N10	Reference T18 NCBITAXON:105843	Anaerobutyricum soehngenii
N11	Reference T20 NCIT:C123623	Metabolic Response
N12	Reference T23 NCIT:C84442	Metabolic Syndrome
N13	Reference T26 NCIT:C84442	Metabolic Syndrome
N14	Reference T27 NCBITAXON:105843	Anaerobutyricum soehngenii
N15	Reference T31 NCBITAXON:105843	Anaerobutyricum soehngenii
N16	Reference T33 CHEBI:80270	Glucagon-like peptide 1
N17	Reference T34 CHEBI:80270	Glucagon-like peptide 1
N18	Reference T36 CHEBI:3098	bile acid
N19	Reference T38 CHEBI:80270	Glucagon-like peptide 1
N20	Reference T39 NCBITAXON:105843	Anaerobutyricum soehngenii
N21	Reference T43 GENE:5968	REG1B
N22	Reference T45 CHEBI:80270	Glucagon-like peptide 1
N23	Reference T49 NCBITAXON:105843	Anaerobutyricum soehngenii
N24	Reference T50 GENE:5968	REG1B
N25	Reference T52 CHEBI:17968	butyrate
N26	Reference T53 CHEBI:8005	peptidoglycan
N27	Reference T54 NCBITAXON:105843	Anaerobutyricum soehngenii
N28	Reference T55 NCBITAXON:105843	Anaerobutyricum soehngenii
N29	Reference T57 MESH:D000085002	Glycemic Control
N30	Reference T59 CHEBI:80270	Glucagon-like peptide 1
N31	Reference T60 GENE:5968	REG1B
N32	Reference T61 GENE:5968	REG1B
N33	Reference T62 OCHV:C0920563	insulin sensitivity
N34	Reference T64 NCIT:C84442	Metabolic Syndrome
